Zitvogel L - Search Results

1

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.

Ullrich E, Bonmort M, Mignot G, Chaput N, Taieb J, Ménard C, Viaud S, Tursz T, Kroemer G, Zitvogel L. Ullrich E, et al. Among authors: zitvogel l. Cancer Res. 2007 Feb 1;67(3):851-3. doi: 10.1158/0008-5472.CAN-06-3766. Cancer Res. 2007. PMID: 17283111 Review.

2

Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects.

Fernandez N, Duffour MT, Perricaudet M, Lotze MT, Tursz T, Zitvogel L. Fernandez N, et al. Among authors: zitvogel l. Cytokines Cell Mol Ther. 1998 Mar;4(1):53-65. Cytokines Cell Mol Ther. 1998. PMID: 9557217 Review.

3

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Fernandez NC, et al. Among authors: zitvogel l. Nat Med. 1999 Apr;5(4):405-11. doi: 10.1038/7403. Nat Med. 1999. PMID: 10202929

4

[Antitumor cellular immunotherapy: the breakthrough of dendritic cells].

Angevin E, André F, Zitvogel L. Angevin E, et al. Among authors: zitvogel l. Bull Cancer. 2000 Jan;87(1):107-15. Bull Cancer. 2000. PMID: 10673639 Free article. Review. French. No abstract available.

5

Dendritic cell-based immunotherapy of cancer.

Zitvogel L, Angevin E, Tursz T. Zitvogel L, et al. Ann Oncol. 2000;11 Suppl 3:199-205. doi: 10.1093/annonc/11.suppl_3.199. Ann Oncol. 2000. PMID: 11079142 Free article. Review. No abstract available.

6

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. Wolfers J, et al. Among authors: zitvogel l. Nat Med. 2001 Mar;7(3):297-303. doi: 10.1038/85438. Nat Med. 2001. PMID: 11231627

7

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, Tursz T, Angevin E, Lemonnier FA, Wakasugi H, Zitvogel L. Ikarashi Y, et al. Among authors: zitvogel l. J Exp Med. 2001 Oct 15;194(8):1179-86. doi: 10.1084/jem.194.8.1179. J Exp Med. 2001. PMID: 11602646 Free PMC article.

8

Malignant effusions and immunogenic tumour-derived exosomes.

Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L. Andre F, et al. Among authors: zitvogel l. Lancet. 2002 Jul 27;360(9329):295-305. doi: 10.1016/S0140-6736(02)09552-1. Lancet. 2002. PMID: 12147373

9

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

Schartz NE, Chaput N, André F, Zitvogel L. Schartz NE, et al. Among authors: zitvogel l. Curr Opin Mol Ther. 2002 Aug;4(4):372-81. Curr Opin Mol Ther. 2002. PMID: 12222875 Review.

10

Tumor-derived exosomes: a new source of tumor rejection antigens.

André F, Schartz NE, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L. André F, et al. Among authors: zitvogel l. Vaccine. 2002 Dec 19;20 Suppl 4:A28-31. doi: 10.1016/s0264-410x(02)00384-5. Vaccine. 2002. PMID: 12477425 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters